Random

COVID-19

Featured Neuroscience Open Neuroscience Articles

·April 6, 2020·5 min read

A new antiviral drug heading into clinical trials offers hope for COVID-19

EIDD-2801, a new antiviral drug, has the potential to treat coronavirus. A new study reveals the drug can prevent severe lung injury in mouse models and cultured human lung cells infected with COVID-19. The drug will soon be ready for human testing.

Featured Neurology Neuroscience

·November 30, 2020·5 min read

How COVID-19 Reaches the Brain

SARS-CoV-2, the virus responsible for COVID-19 enters the brain via neurons in the olfactory mucosa.

This shows how the antibody works to combat covid-19

Featured Genetics Neuroscience Open Neuroscience Articles

·December 22, 2020·5 min read

Neuroscientists Isolate Promising Mini Antibodies Against COVID-19 From a Llama

Researchers have isolated a set of antibodies from a llama which show promise for the treatment of COVID-19. The NIH-CoVnB-112 nanoantibody bound to ACE2 receptors up to ten times stronger than other lab-produced antibodies. The nanoantibody stuck directly to the ACE2 receptor binding portion of the SARS_CoV-2 spike protein. The protein could be effective in preventing coronavirus infection.

Featured Neuroscience Open Neuroscience Articles

·March 25, 2020·3 min read

COVID-19 should be wake-up call for robotics research

Robots could help perform the "dull, dirty, and dangerous" pandemic response jobs, limiting human exposure to COVID-19.

This shows a woman in a facemask holding a flower

Featured Neuroscience

·February 2, 2022·5 min read

Mechanism Behind Loss of Smell With COVID-19 Revealed

Infection with the SARS_CoV-2 virus causes dials down the action of olfactory receptors, resulting in smell loss associated with COVID-19.

Featured Neurology Neuroscience

·June 17, 2022·2 min read

Long COVID Risk Less During Omicron Compared to Delta

The odds of those infected with the Omicron variant of COVID-19 suffering long-COVID are 20-50% less than those infected during the Delta wave of COVID.

Featured Neuroscience Open Neuroscience Articles

·March 30, 2020·3 min read

Wastewater test could provide early warning of COVID-19

Researchers have developed a new paper device that can be put into wastewater systems to detect COVID-19. The test works by picking up on biomarkers of the virus in feces and urine. The test can help monitor communities most at risk of the virus and help agencies to restrict the movement of the population at risk.

This is a graphic abstract from the study

Featured Neuroscience

·April 11, 2020·5 min read

Ion channel VRAC enhances immune response against viruses

Findings suggest cell-to-cell transmission of cGAMP via LRRC8/VRAC ion channels is central to effective antiviral immunity.

Featured Neuroscience

·April 1, 2020·4 min read

Antiviral used to treat cat coronavirus could hold key to COVID-19

A drug used to treat feline infectious peritonitis, an often fatal coronavirus infection in cats, may hold the key for developing a treatment for human COVID-19.

Featured Neuroscience Open Neuroscience Articles

·June 6, 2020·6 min read

Microglia in the olfactory bulb have a nose for protecting the brain from infection

Microglia help limit infection to the olfactory bulb and protects neurons from damage that could occur as a result of viral infection.

Featured Neuroscience Open Neuroscience Articles Psychology

·November 13, 2020·6 min read

Antidepressant May Prevent Severe COVID-19, Trial Suggests

A new small scale study reveals the antidepressant fluvoxamine may be a new tool in the fight against COVID-19. Researchers report fluvoxamine reduced the severity of coronavirus symptoms and hospitalizations.

Featured Neuroscience

·April 20, 2020·3 min read

Early antibody testing results reveal more COVID-19 infections than confirmed cases

The first round of antibody testing in L.A country reveals approximately 4.1% of the adult population has COVID-19 antibodies. Adjusting for margin of error, between 2.8% to 5.6% of the adult population has antibodies to the virus. This means between 221,000 and 442,000 adults in the Los Angeles area have been infected with coronavirus. The estimate is up to 55 times higher than confirmed cases reported for the area.

1 2 3 … 36

COVID-19

A new antiviral drug heading into clinical trials offers hope for COVID-19

How COVID-19 Reaches the Brain

Neuroscientists Isolate Promising Mini Antibodies Against COVID-19 From a Llama

COVID-19 should be wake-up call for robotics research

Mechanism Behind Loss of Smell With COVID-19 Revealed

Long COVID Risk Less During Omicron Compared to Delta

Wastewater test could provide early warning of COVID-19

Ion channel VRAC enhances immune response against viruses

Antiviral used to treat cat coronavirus could hold key to COVID-19

Microglia in the olfactory bulb have a nose for protecting the brain from infection

Antidepressant May Prevent Severe COVID-19, Trial Suggests

Early antibody testing results reveal more COVID-19 infections than confirmed cases

GPS of the Brain: Marmoset Gaze Reveals New Insights into Spatial Navigation

BigNeuron: Revolutionizing Neuron Reconstruction with AI

Vitamin D’s Crucial Role in Dopamine Function and Schizophrenia

Canine Brain Atlas Sheds Light on Evolution of Human Brain Function

Subscribe